ubmslateNT-logo-ubm

NT Mobile Menu

Search form

Topics:

Parkinson disease

Parkinson disease

Researchers studied the complicated relationship between GRIN2A, caffeine consumption, creatine, and progression of Parkinson disease.

From the first hand-held vagus nerve stimulator for episodic cluster headache to a TMS therapy system for depression, we highlight 5 new technologies.

Research at AAN 2017 highlights research of genes that may help predict the likelihood of developing Parkinson disease and progression of the disease.

Patients with Parkinson disease experiencing “off” episodes on levodopa/carbidopa now have another treatment option.

April news includes tools to manage brain injury and predict recovery, new drug hits and misses, and an updated epilepsy classification system.

How frequently are your patients with Parkinson disease reporting pain and is that pain effectively managed?

March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.

Pages

Subscribe to Parkinson disease on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.